| April Williams-rutt, OD | |
|
860 S Watson Rd Ste 107, Buckeye, AZ 85326 | |
| (623) 386-8802 | |
| (623) 327-1669 |
| Full Name | April Williams-rutt |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 18 Years |
| Location | 860 S Watson Rd Ste 107, Buckeye, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447345350 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT-001539 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nationwide Optometry P.c. | 6901033075 | 41 |
News Archive
Synthego, a leading provider of genome engineering solutions, officially launches today. Synthego's flagship product line, CRISPRevolution, features synthetic guide RNA products designed to accelerate CRISPR/Cas9 and Cpf1 genome engineering research. CRISPRevolution is the first product line to offer economical access to fully synthetic RNA for high fidelity editing and increased precision in genome editing.
Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year sole source microscopic urinalysis contract agreement with group purchasing organization Novation. Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances, and 5,500 members of Provista, LLC, representing 28,000 sites.
Researchers at Micro Orthopaedics, Zhongnan Hospital of Wuhan University, led by Dr. Ai-xi Yu, have suggested that articular cartilage defects can be repaired by a novel thermo-sensitive injectable hydrogel engineered with gene modified bone marrow mesenchymal stromal cells.
Wake Forest Institute for Regenerative Medicine scientists are working on a promising approach for treatment of chronic kidney disease - regeneration of damaged tissues using therapeutic cells.
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced that enrollment has initiated and the first patient was dosed in a Phase 1b clinical trial of SYN-004, an investigational oral beta-lactamase enzyme for the prevention of Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.
› Verified 4 days ago
| Provider Name | Nationwide Optometry P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326472945 PECOS PAC ID: 6901033075 Enrollment ID: O20131217000251 |
News Archive
Synthego, a leading provider of genome engineering solutions, officially launches today. Synthego's flagship product line, CRISPRevolution, features synthetic guide RNA products designed to accelerate CRISPR/Cas9 and Cpf1 genome engineering research. CRISPRevolution is the first product line to offer economical access to fully synthetic RNA for high fidelity editing and increased precision in genome editing.
Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year sole source microscopic urinalysis contract agreement with group purchasing organization Novation. Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances, and 5,500 members of Provista, LLC, representing 28,000 sites.
Researchers at Micro Orthopaedics, Zhongnan Hospital of Wuhan University, led by Dr. Ai-xi Yu, have suggested that articular cartilage defects can be repaired by a novel thermo-sensitive injectable hydrogel engineered with gene modified bone marrow mesenchymal stromal cells.
Wake Forest Institute for Regenerative Medicine scientists are working on a promising approach for treatment of chronic kidney disease - regeneration of damaged tissues using therapeutic cells.
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced that enrollment has initiated and the first patient was dosed in a Phase 1b clinical trial of SYN-004, an investigational oral beta-lactamase enzyme for the prevention of Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| April Williams-rutt, OD 220 N Mckemy, Chandler, AZ 85226 Ph: (480) 961-1865 | April Williams-rutt, OD 860 S Watson Rd Ste 107, Buckeye, AZ 85326 Ph: (623) 386-8802 |
News Archive
Synthego, a leading provider of genome engineering solutions, officially launches today. Synthego's flagship product line, CRISPRevolution, features synthetic guide RNA products designed to accelerate CRISPR/Cas9 and Cpf1 genome engineering research. CRISPRevolution is the first product line to offer economical access to fully synthetic RNA for high fidelity editing and increased precision in genome editing.
Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year sole source microscopic urinalysis contract agreement with group purchasing organization Novation. Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances, and 5,500 members of Provista, LLC, representing 28,000 sites.
Researchers at Micro Orthopaedics, Zhongnan Hospital of Wuhan University, led by Dr. Ai-xi Yu, have suggested that articular cartilage defects can be repaired by a novel thermo-sensitive injectable hydrogel engineered with gene modified bone marrow mesenchymal stromal cells.
Wake Forest Institute for Regenerative Medicine scientists are working on a promising approach for treatment of chronic kidney disease - regeneration of damaged tissues using therapeutic cells.
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced that enrollment has initiated and the first patient was dosed in a Phase 1b clinical trial of SYN-004, an investigational oral beta-lactamase enzyme for the prevention of Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.
› Verified 4 days ago
Nationwide Optometry Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 860 S Watson Rd Ste 107, Buckeye, AZ 85326 Phone: 623-386-8802 Fax: 623-327-1669 | |
Jennifer Elhabiby, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1111 N Verrado Way, Buckeye, AZ 85326 Phone: 480-618-4015 |